Tirzepatide 15 mg | MounjaPro

Tirzepatide 15 mg contains tirzepatide, a synthetic peptide that activates both glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. This dual activity influences glucose regulation, insulin secretion, appetite, and energy balance.

Tirzepatide has established clinical applications in type 2 diabetes and, under specific brand indications, chronic weight management. The appropriate indication and formulation depend on the individual patient and jurisdiction.

Common treatment considerations include gastrointestinal effects such as nausea, diarrhea, vomiting, constipation, and reduced appetite. More serious risks can also occur, so prescribing decisions should take account of medical history and concurrent treatments.